がん治療用臨床栄養世界の市場レポート 2024年

がん治療用臨床栄養市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR5.7%で61億4,000万米ドルに成長します。予測期間の成長は、個別化医療と精密栄養へのシフト、患者を支援する臨床栄養介入に対する需要の高まり、栄養ががん治療の結果に与える影響に対する認識の高まり、がん治療の進歩、がん治療における構造化された臨床栄養経路の統合によってもたらされると予想されます。予測期間の主な動向としては、栄養バイオマーカー研究の進展、栄養製品および送達システムにおける技術革新、腫瘍専門医間の連携の強化、栄養科学の継続的な進歩、この分野における継続的な研究開発などが挙げられます。

がんの有病率の増加は、がん治療用臨床栄養市場の今後の成長を促進すると予想されます。がんには、制御不能な細胞増殖と転移の可能性を特徴とするさまざまな疾患が含まれます。がん患者の増加は平均寿命の延長によるところが大きく、その結果、高齢化人口が増加してがんにかかりやすくなっています。がん治療用臨床栄養学には、がん患者特有のニーズに合わせた専門的な食事管理と栄養サポートが含まれ、治療成果を最適化します。例えば、米国に本部を置く政府間組織である世界保健機関（WHO）は2024年2月、2050年までに新たに発生するがん患者数を約3,500万人と予測し、2022年の推定患者数2,000万人から77％増加すると発表しました。その結果、がん有病率の増加ががん治療用臨床栄養市場の拡大に拍車をかけています。

がん治療用臨床栄養市場の大手企業は、競争上の優位性を獲得するため、経口栄養補助食品など、がん患者向けの製品を革新しています。経口栄養補助食品は、特定の病状を持つ患者に的を絞った栄養サポートを提供するために特別に処方された栄養補助食品です。例えば、2022年7月、スイスを拠点とする食品・飲料加工会社ネスレは、中国初のフーズ・オーラル・インパクト・スイ・スーを発売しました。この製品にはアルギニンと魚のオメガ3が含まれ、中国の規制当局による5年間の承認プロセスを経て、腫瘍関連疾患の患者のための特別医療目的（FSMP）用の他の基本栄養成分も含まれています。Oral Impact Su Yi Suは、がん治療中の患者特有の栄養ニーズを満たすために特別に承認されたFSMP栄養補助食品です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のがん治療用臨床栄養世界市場レポート 2024年：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のがん治療用臨床栄養世界の市場の実績レポート 2024年：規模と成長、2018年～2023年
• 世界のがん治療用臨床栄養世界の市場の予測レポート 2024年：規模と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のがん治療用臨床栄養世界市場レポート 2024年：タイプ別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 経口栄養
• 経腸栄養
• 経腸栄養剤
• 世界のがん治療用臨床栄養世界市場レポート 2024年：がんタイプ別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 頭頸部がん
• 胃がんおよび消化器がん
• 血液がん
• 乳がん
• 肺がん
• その他のがんタイプ
• 世界のがん治療用臨床栄養世界市場レポート 2024年：年齢層別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 成人
• 小児
• 世界のがん治療用臨床栄養世界市場レポート 2024年：販売チャネル別、実績と予測、2018年～2023年、2023年～2028年、2033年
• オンライン
• 小売り
• 機関投資家向け販売

第7章 地域別・国別分析

• 世界のがん治療用臨床栄養世界市場レポート 2024年：地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 世界のがん治療用臨床栄養世界市場レポート 2024年：国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• がん治療用臨床栄養世界の市場レポート 2024年：競合情勢
• がん治療用臨床栄養世界の市場レポート 2024年：企業プロファイル
  • Pfizer Inc.
  • Bayer AG
  • Abbott Nutrition
  • GlaxoSmithKline plc
  • Reckitt Benckiser Group plc

第31章 その他の大手企業と革新的企業

• Evonik Industries AG
• Baxter International Inc.
• Otsuka Holdings Co. Ltd.
• B. Braun Melsungen AG
• Koninklijke DSM N.V.
• Glanbia plc
• Kyowa Kirin Co. Ltd
• Nestle Health Science S.A.
• Danone Nutricia
• BioGaia AB
• Meiji Holdings Company Ltd.
• Hormel Health Labs
• Victus Inc.
• Taiho Pharmaceutical Co. Ltd.
• Global Health Products Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Clinical nutrition for cancer care involves specialized dietary support and interventions tailored to address the nutritional needs of cancer patients throughout their treatment journey. This includes personalized nutrition plans designed to manage symptoms, optimize treatment outcomes, and enhance the overall quality of life for individuals undergoing cancer therapy.

The primary types of clinical nutrition for cancer care include oral nutrition, parenteral nutrition, and enteral feeding formulas. Oral nutrition refers to the consumption of food and fluids by mouth to provide essential nutrients, crucial for supporting those undergoing cancer treatment. This approach is applicable to various cancer types, such as head and neck cancer, stomach and gastrointestinal cancers, blood cancer, breast cancer, lung cancer, and others, for both adults and children. Clinical nutrition for cancer care is distributed through sales channels such as online platforms, retail outlets, and institutional sales.

The clinical nutrition for cancer care market research report is one of a series of new reports from The Business Research Company that provides clinical nutrition for cancer care market statistics, including the clinical nutrition for cancer care industry global market size, regional shares, competitors with the clinical nutrition for cancer care market share, detailed clinical nutrition for cancer care market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical nutrition for cancer care industry. These clinical nutrition for cancer care market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The clinical nutrition for cancer care market size has grown strongly in recent years. It will grow from $4.67 billion in 2023 to $4.92 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth observed in the historic period can be attributed to heightened awareness of nutritional needs, the rise of precision nutrition methods, changes in healthcare policies and reimbursement models, surgical cancer interventions, and increasing interest in functional foods, nutraceuticals, and dietary supplements.

The clinical nutrition for cancer care market size is expected to see strong growth in the next few years. It will grow to $6.14 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period is expected to result from a shift towards personalized medicine and precision nutrition, higher demand for clinical nutrition interventions to support patients, greater awareness of nutrition's impact on cancer treatment outcomes, advancements in cancer treatments, and the integration of structured clinical nutrition pathways in oncology. Key trends for the forecast period include progress in nutritional biomarker research, technological innovations in nutritional products and delivery systems, enhanced collaboration among oncologists, ongoing advancements in nutritional science, and continued research and development in the field.

The increasing prevalence of cancer is expected to drive the growth of the clinical nutrition for cancer care market in the future. Cancer encompasses a range of diseases characterized by uncontrolled cell growth and the potential for metastasis. The rise in cancer cases is largely due to increased life expectancy, resulting in a larger aging population more vulnerable to cancer. Clinical nutrition for cancer care involves specialized dietary management and nutritional support tailored to the unique needs of cancer patients to optimize treatment outcomes. For example, in February 2024, the World Health Organization, an intergovernmental organization based in the US, projected approximately 35 million new cancer cases by 2050, a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing prevalence of cancer is fueling the expansion of the clinical nutrition for cancer care market.

Leading companies in the clinical nutrition for cancer care market are innovating products for cancer patients, such as oral nutritional supplements, to gain a competitive advantage. Oral nutritional supplements are specially formulated dietary products designed to provide targeted nutritional support for individuals with specific medical conditions. For instance, in July 2022, Nestle, a Switzerland-based food and drink processing company, introduced China's first Foods Oral Impact Su Yi Su. This product contains arginine and fish omega-3, along with other basic nutritional ingredients for special medical purposes (FSMP) for patients with tumor-related conditions, following a five-year approval process by the Chinese regulator. Oral Impact Su Yi Su is a FSMP nutritional supplement specifically approved to meet the unique nutritional needs of individuals undergoing cancer treatment.

In January 2024, Danone S.A., a French food-products corporation, partnered with Resilience to create a groundbreaking nutrition and oncology module integrated into Resilience's digital oncology solution. This partnership aims to improve nutritional care for cancer patients by addressing cancer-related malnutrition, which affects up to 70% of cancer patients. Resilience, a US-based digital oncology company, offers clinical nutrition support for cancer patients.

Major companies operating in the clinical nutrition for cancer care market are Pfizer Inc., Bayer AG, Abbott Nutrition, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Evonik Industries AG, Baxter International Inc., Otsuka Holdings Co. Ltd., B. Braun Melsungen AG, Koninklijke DSM N.V., Glanbia plc, Kyowa Kirin Co. Ltd, Nestle Health Science S.A., Danone Nutricia, BioGaia AB, Meiji Holdings Company Ltd., Hormel Health Labs, Victus Inc., Taiho Pharmaceutical Co. Ltd., Global Health Products Inc

North America was the largest region in the clinical nutrition for cancer care market in 2023. The regions covered in the clinical nutrition for cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical nutrition for cancer care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical nutrition for cancer care market consists of sales of clinical nutrition products such as high-protein supplements and dietary supplements rich in antioxidants, vitamins, and minerals. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Nutrition For Cancer Care Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical nutrition for cancer care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical nutrition for cancer care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical nutrition for cancer care market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Oral Nutrition; Parenteral Nutrition; Enteral Feeding Formulas
• 2) By Cancer Type: Head And Neck Cancer; Stomach And Gastrointestinal Cancers; Blood Cancer; Breast Cancer; Lung Cancer; Other Cancer Types
• 3) By Age Group: Adult; Pediatric
• 4) By Sales Channel: Online; Retail; Institutional Sales
• Companies Mentioned: Pfizer Inc.; Bayer AG; Abbott Nutrition; GlaxoSmithKline plc; Reckitt Benckiser Group plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Nutrition For Cancer Care Market Characteristics

3. Clinical Nutrition For Cancer Care Market Trends And Strategies

4. Clinical Nutrition For Cancer Care Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Clinical Nutrition For Cancer Care Market Size and Growth

• 5.1. Global Clinical Nutrition For Cancer Care Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Clinical Nutrition For Cancer Care Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Clinical Nutrition For Cancer Care Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Clinical Nutrition For Cancer Care Market Segmentation

• 6.1. Global Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral Nutrition
• Parenteral Nutrition
• Enteral Feeding Formulas
• 6.2. Global Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Head And Neck Cancer
• Stomach And Gastrointestinal Cancers
• Blood Cancer
• Breast Cancer
• Lung Cancer
• Other Cancer Types
• 6.3. Global Clinical Nutrition For Cancer Care Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Adult
• Pediatric
• 6.4. Global Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Online
• Retail
• Institutional Sales

7. Clinical Nutrition For Cancer Care Market Regional And Country Analysis

• 7.1. Global Clinical Nutrition For Cancer Care Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Clinical Nutrition For Cancer Care Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Clinical Nutrition For Cancer Care Market

• 8.1. Asia-Pacific Clinical Nutrition For Cancer Care Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Clinical Nutrition For Cancer Care Market

• 9.1. China Clinical Nutrition For Cancer Care Market Overview
• 9.2. China Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Clinical Nutrition For Cancer Care Market

• 10.1. India Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Clinical Nutrition For Cancer Care Market

• 11.1. Japan Clinical Nutrition For Cancer Care Market Overview
• 11.2. Japan Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Clinical Nutrition For Cancer Care Market

• 12.1. Australia Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Clinical Nutrition For Cancer Care Market

• 13.1. Indonesia Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Clinical Nutrition For Cancer Care Market

• 14.1. South Korea Clinical Nutrition For Cancer Care Market Overview
• 14.2. South Korea Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Clinical Nutrition For Cancer Care Market

• 15.1. Western Europe Clinical Nutrition For Cancer Care Market Overview
• 15.2. Western Europe Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Clinical Nutrition For Cancer Care Market

• 16.1. UK Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Clinical Nutrition For Cancer Care Market

• 17.1. Germany Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Clinical Nutrition For Cancer Care Market

• 18.1. France Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Clinical Nutrition For Cancer Care Market

• 19.1. Italy Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Clinical Nutrition For Cancer Care Market

• 20.1. Spain Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Clinical Nutrition For Cancer Care Market

• 21.1. Eastern Europe Clinical Nutrition For Cancer Care Market Overview
• 21.2. Eastern Europe Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Clinical Nutrition For Cancer Care Market

• 22.1. Russia Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Clinical Nutrition For Cancer Care Market

• 23.1. North America Clinical Nutrition For Cancer Care Market Overview
• 23.2. North America Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Clinical Nutrition For Cancer Care Market

• 24.1. USA Clinical Nutrition For Cancer Care Market Overview
• 24.2. USA Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Clinical Nutrition For Cancer Care Market

• 25.1. Canada Clinical Nutrition For Cancer Care Market Overview
• 25.2. Canada Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Clinical Nutrition For Cancer Care Market

• 26.1. South America Clinical Nutrition For Cancer Care Market Overview
• 26.2. South America Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Clinical Nutrition For Cancer Care Market

• 27.1. Brazil Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Clinical Nutrition For Cancer Care Market

• 28.1. Middle East Clinical Nutrition For Cancer Care Market Overview
• 28.2. Middle East Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Clinical Nutrition For Cancer Care Market

• 29.1. Africa Clinical Nutrition For Cancer Care Market Overview
• 29.2. Africa Clinical Nutrition For Cancer Care Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Clinical Nutrition For Cancer Care Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Clinical Nutrition For Cancer Care Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Clinical Nutrition For Cancer Care Market Competitive Landscape And Company Profiles

• 30.1. Clinical Nutrition For Cancer Care Market Competitive Landscape
• 30.2. Clinical Nutrition For Cancer Care Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Abbott Nutrition
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. GlaxoSmithKline plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Reckitt Benckiser Group plc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Clinical Nutrition For Cancer Care Market Other Major And Innovative Companies

• 31.1. Evonik Industries AG
• 31.2. Baxter International Inc.
• 31.3. Otsuka Holdings Co. Ltd.
• 31.4. B. Braun Melsungen AG
• 31.5. Koninklijke DSM N.V.
• 31.6. Glanbia plc
• 31.7. Kyowa Kirin Co. Ltd
• 31.8. Nestle Health Science S.A.
• 31.9. Danone Nutricia
• 31.10. BioGaia AB
• 31.11. Meiji Holdings Company Ltd.
• 31.12. Hormel Health Labs
• 31.13. Victus Inc.
• 31.14. Taiho Pharmaceutical Co. Ltd.
• 31.15. Global Health Products Inc.

32. Global Clinical Nutrition For Cancer Care Market Competitive Benchmarking

33. Global Clinical Nutrition For Cancer Care Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Clinical Nutrition For Cancer Care Market

35. Clinical Nutrition For Cancer Care Market Future Outlook and Potential Analysis

• 35.1 Clinical Nutrition For Cancer Care Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Clinical Nutrition For Cancer Care Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Clinical Nutrition For Cancer Care Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer